非組織特異性堿性磷酸酶(ALPL)活性蛋白
Active Alkaline Phosphatase, Tissue-nonspecific (ALPL)
BALP; BSAP; HOPS; AP-TNAP; TNSALP; Bone Alkaline Phosphatase; Alkaline Phosphatase,Tissue-Nonspecific Isozyme; Alkaline Phosphatase, Liver/Bone/Kidney
- 編號APB091Bo61
- 物種Bos taurus; Bovine (Cattle,牛)相同的名稱,不同的物種。
- 緩沖液成份磷酸鹽緩沖液(pH7.4,含有 0.01% SKL, 1mM DTT, 5% Trehalose和Proclin300.)
- 性狀凍干粉
- 純度> 90%
- 等電點6.8
- 應用Cell?culture;?Activity?Assays.
- 下載英文說明書 中文說明書
- 規(guī)格10μg50μg200μg1mg5mg
- 價格¥ 2006¥ 5016¥ 10032¥ 30096¥ 75240
- 欲了解實際交易價格和更多情況,請與當?shù)亟?jīng)銷商聯(lián)系!
活性實驗
Alkaline phosphatase tissue-nonspecific (ALPL) is a membrane-bound glycoprotein expressed in bone, liver, kidney and other tissues. It corely mediates skeletal and dental mineralization, regulates vitamin B6 metabolism and adaptive thermogenesis. Mutations in its gene cause hypophosphatasia, leading to defective skeletal mineralization.This method is based on the principle that alkaline phosphatase can catalyze the hydrolysis of p-nitrophenyl phosphate (PNPP) to produce p-nitrophenol, which has a maximum absorption peak at 405 nm, and the activity of alkaline phosphatase is determined by quantifying the generated p-nitrophenol. First, perform 2-fold serial dilution of the protein starting from 100 μg/mL to prepare 7 gradient concentrations with an additional buffer control group, then dilute the PNPP substrate to 20 mM with the assay buffer (50 mM Tris, 1 mM MgCl2, pH 9.0), add 50 μL of the diluted protein sample and 50 μL of 20 mM PNPP substrate to each well of the microplate, and conduct kinetic absorbance reading at 405 nm for 5 consecutive minutes. For the preparation of the standard curve, first dilute the p-nitrophenol standard to 1 mM with the assay buffer, then make 2-fold serial dilutions to obtain 7 gradient concentrations, add 100 μL of each standard dilution to the corresponding wells, set a blank control well with only 100 μL of assay buffer, and finally measure the absorbance of all wells at 400 nm.<br/>One unit of enzyme activity is defined as the 1 μg of enzyme required to hydrolyzes 1pmol PNPP to produce PNP in 1 min at 37°C. The specific activity of recombinant cattle ALPL is 1146 pmol/min/μg.<br/>Specific Activity (pmol/min/μg)=<br/>△OD=Adjusted for Substrate Blank<br/>F=Conversion Factor(convert from standard curve of p-nitrocatechol)<br/>T= Time<br/>N=Amount of enzyme
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復凍融。2-8°C不超過一個月,-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當?shù)臈l件下存儲,損失率低于5%。
增值服務
相關產(chǎn)品
| 編號 | 適用物種:Bos taurus; Bovine (Cattle,牛) | 應用(僅供研究使用,不用于臨床診斷!) |
| RPB091Bo01 | 非組織特異性堿性磷酸酶(ALPL)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| EPB091Bo61 | 非組織特異性堿性磷酸酶(ALPL)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| APB091Bo61 | 非組織特異性堿性磷酸酶(ALPL)活性蛋白 | Cell?culture;?Activity?Assays. |
| PAB091Bo01 | 非組織特異性堿性磷酸酶(ALPL)多克隆抗體 | WB; IHC; ICC; IP. |
參考文獻
| 雜志 | 參考文獻 |
| Journal of Materials Science: Materials in Medicine | Osteopenic bone cell response to strontium-substituted hydroxyapatite[SpringerLink: n8233337w171v451] |
| Osteoporosis International | Dextromethorphan inhibits osteoclast differentiation by suppressing RANKL-induced nuclear factor-κB activation[PubMed: 23400250] |
| Journal of Applied Toxicology | Chronic exposure to low concentrations of strontium 90 affects bone physiology but not the hematopoietic system in mice[Wiley: Source] |
| Acta Pharmacologica Sinica | The antidepressant bupropion exerts alleviating properties in an ovariectomized osteoporotic rat model[Pubmed:25544359] |
| Biomedical Materials | Enhanced differentiation of osteoblastic cells on novel chitosan/β-1, 3-glucan/bioceramic scaffolds for bone tissue regeneration[Pubmed:25586067] |
| Pharmacology | Effect of Mirtazapine on Rat Bone Tissue after Orchidectomy[PubMed: 25871861] |
| J Biomed Mater Res A. | New method for the fabrication of highly osteoconductive β-1,3-glucan/HA scaffold for bone tissue engineering: Structural, mechanical, and biological characterization.[Pubmed:27239050] |
| J Bone Miner Metab | MiR-142-5p promotes bone repair by maintaining osteoblast activity[Pubmed:27085967] |
| Journal of Biomedical Materials Research | New method for the fabrication of highly osteoconductive β‐1, 3‐glucan/HA scaffold for bone tissue engineering: Structural, mechanical, and biological …[doi:10.1002] |
| Journal of?Bone?and?Mineral?Metabolism | MiR?142?5p promotes bone repair by maintaining osteoblast activity[pubmed:27085967] |
| Scientific Reports | Hydrolysis of Extracellular Pyrophosphate increases in post-hemodialysis plasma[Pubmed:30038263] |
| International?Journal?of?Molecular?Sciences? | Suppression Effect of Astaxanthin on Osteoclast Formation In Vitro and Bone Loss In Vivo[Pubmed:29562730] |
| Pharmacology | Effects of Amlodipine on Bone Metabolism in Orchidectomised Spontaneously Hypertensive Rats[Pubmed:29898457] |
| Experimental and Therapeutic Medicine | Combination therapy with BMP?2 and psoralen enhances fracture healing in ovariectomized mice[10.3892:etm.2018.6353] |
| American Journal of Translational?Research | Long non-coding RNA SNHG7 promotes the fracture repair through negative modulation of miR-9[] |
| The effect of low temperature atmospheric nitrogen plasma on MC3T3-E1 preosteoblast proliferation and differentiation in vitro[] | |
| International Journal of Biomaterials | Bovine Hydroxyapatite-Based Bone Scaffold with Gentamicin Accelerates Vascularization and Remodeling of Bone Defect[34104195] |



